Oticara
Highly Engaged Employees
Manufacturing · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.oticara.comRevenue
<$5 MillionIndustry
About Oticara
Oticara Org Chart
Is Oticara your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Oticara has new funding data
Check if Oticara has recently received funding, and reach out quickly before it becomes old news!
Check out if Oticara is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Oticara had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Oticara recently announced quarterly report
Oticara, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Oticara launches new products
Congratulate Masked Content for being promoted to Masked Content at Oticara
Recommended Actions
Reach out to Masked Content who joined Oticara as Masked Content
Find 3 more new buyers
Compare Similar Companies to Oticara
Compare insights from companies similar to Oticara, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Oticara is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Oticara is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Oticara.
Oticara Tech Stack
A closer look at the technologies used by Oticara
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oticara
Oticara is a clinical-stage biopharmaceutical company focused on developing innovative therapies for Chronic Rhinosinusitis (CRS) using a novel intranasal delivery method. Their investigational product is a single-dose, physician-administered corticosteroid formulation designed to target inflamed sinonasal mucosa, aiming to provide rapid and sustai... Read More